Clough Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $698K | Hold |
6,300
| – | – | 0.07% | 93 |
|
|
2025
Q1 | $706K | Hold |
6,300
| – | – | 0.09% | 84 |
|
|
2024
Q4 | $582K | Hold |
6,300
| – | – | 0.07% | 98 |
|
|
2024
Q3 | $528K | Hold |
6,300
| – | – | 0.05% | 117 |
|
|
2024
Q2 | $432K | Hold |
6,300
| – | – | 0.05% | 108 |
|
|
2024
Q1 | $461K | Hold |
6,300
| – | – | 0.05% | 111 |
|
|
2023
Q4 | $510K | Sell |
6,300
-1,400
| -18% | -$113K | 0.06% | 136 |
|
|
2023
Q3 | $577K | Hold |
7,700
| – | – | 0.06% | 126 |
|
|
2023
Q2 | $593K | Hold |
7,700
| – | – | 0.06% | 145 |
|
|
2023
Q1 | $639K | Hold |
7,700
| – | – | 0.07% | 140 |
|
|
2022
Q4 | $661K | Buy |
+7,700
| New | +$661K | 0.07% | 138 |
|
|
2020
Q3 | – | Sell |
-103,200
| Closed | -$7.94M | – | 129 |
|
|
2020
Q2 | $7.94M | Sell |
103,200
-83,800
| -45% | -$6.45M | 0.78% | 50 |
|
|
2020
Q1 | $14M | Buy |
+187,000
| New | +$14M | 1.39% | 22 |
|
|
2017
Q1 | – | Sell |
-248,322
| Closed | -$17.8M | – | 162 |
|
|
2016
Q4 | $17.8M | Buy |
248,322
+118,822
| +92% | +$8.51M | 1.18% | 29 |
|
|
2016
Q3 | $10.2M | Buy |
129,500
+61,900
| +92% | +$4.9M | 0.53% | 64 |
|
|
2016
Q2 | $5.64M | Buy |
+67,600
| New | +$5.64M | 0.3% | 101 |
|
|
2015
Q3 | – | Sell |
-114,316
| Closed | -$13.4M | – | 208 |
|
|
2015
Q2 | $13.4M | Sell |
114,316
-77,140
| -40% | -$9.03M | 0.51% | 73 |
|
|
2015
Q1 | $18.8M | Buy |
+191,456
| New | +$18.8M | 0.62% | 69 |
|
|
2014
Q2 | – | Sell |
-283,046
| Closed | -$20.1M | – | 204 |
|
|
2014
Q1 | $20.1M | Sell |
283,046
-39,200
| -12% | -$2.78M | 0.63% | 61 |
|
|
2013
Q4 | $24.2M | Sell |
322,246
-9,600
| -3% | -$721K | 0.8% | 45 |
|
|
2013
Q3 | $20.9M | Buy |
331,846
+8,000
| +2% | +$503K | 0.65% | 59 |
|
|
2013
Q2 | $16.6M | Buy |
+323,846
| New | +$16.6M | 0.55% | 64 |
|